CNS PHARMACEUTICAL
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. CNS may also pursue the development of Berubicin to treat additional diseases, including pancreatic and ovarian cancers and lymphoma. CNS may also develop combination therapies that include Berubicin.
CNS PHARMACEUTICAL
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.cnspharma.com
Total Employee:
1+
Status:
Active
Total Funding:
11.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Content Delivery Network Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.cnspharma.com
- Host name: 104.21.32.1
- IP address: 104.21.32.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CNS Pharmaceutical"
CNS Pharmaceuticals | Home
The link you have selected will take you to a site outside CNSPharma.com. CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS Pharmaceuticals does not endorse and is not …See details»
Who We Are - CNS Pharmaceuticals
The link you have selected will take you to a site outside CNSPharma.com. CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS …See details»
CNS Pharmaceutical - Crunchbase Company Profile & Funding
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. CNS may also pursue the development of …See details»
CNS Pharmaceuticals, Inc. (CNSP) - Yahoo Finance
See the company profile for CNS Pharmaceuticals, Inc. (CNSP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
CNS Pharmaceuticals, Inc. | LinkedIn
CNS Pharmaceuticals, Inc. Biotechnology Research Houston, TX 1,168 followers Pre-Clinical Stage Biotech Company Focused on Developing Novel Treatments for Brain TumorsSee details»
CNS Pharmaceuticals, Inc. (CNSP) - Yahoo Finance Canada
See the company profile for CNS Pharmaceuticals, Inc. (CNSP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Contact - CNS Pharmaceuticals
[email protected]. Investor Relations. JTC Team T: 908-824-0775 [email protected] [email protected]. Transfer Agent. Continental Stock Transfer & Trust Company 1 State …See details»
CNS Pharmaceuticals, Inc. S-1
Our principal executive offices are located at 2100 West Loop South, Suite 900, Houston, TX 77027 and our telephone number is (800) 946-9185. Our website address is …See details»
CNS Pharmaceuticals, Inc. (CNSP) Company Profile & Overview
2100 West Loop South, Suite 900 Houston, Texas 77027 United StatesSee details»
CNS Pharmaceuticals - Overview, News & Similar companies
Jan 29, 2024 CNS Pharmaceuticals contact info: Phone number: (800) 946-9185 Website: www.cnspharma.com What does CNS Pharmaceuticals do? CNS Pharmaceuticals is …See details»
CNS Pharmaceuticals, Inc. 10-Q
Table of Contents SECURITIES AND EXCHANGE COMMISSION. Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE …See details»
CNS Pharmaceuticals - Craft
Sep 18, 2024 CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. It develops Berubicin, a drug for the …See details»
CNS Pharmaceuticals Inc, CNSP:NAQ profile - FT.com
Jan 3, 2025 CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of …See details»
CNS Pharmaceuticals | CNS Pharmaceuticals
Jan 18, 2024 The link you have selected will take you to a site outside CNSPharma.com. CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. …See details»
CNS Pharmaceuticals Announces Pricing of Registered Direct …
Jul 3, 2024 HOUSTON, TX / ACCESSWIRE / July 3, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the …See details»
Investor Relations - CNS Pharmaceuticals
The link you have selected will take you to a site outside CNSPharma.com. CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS …See details»
Nutraceutical Contract Manufacturer in Canada | CSN Pharma
Grow with CSN Pharma - A leading Canadian Supplement Manufacturer in Vancouver. GMP & SQF certified, compliant with Health Canada, CFIA, and FDA standards.See details»
8-K - assets.cnspharma.com
Proposal 2. Nasdaq Listing Rule 5635(d) Approval - For purposes of complying with Nasdaq Listing Rule 5635(d), the Company’s stockholders approved the repricing of warrants issued to …See details»
CNS Pharmaceuticals | CNS Pharmaceuticals
Aug 15, 2024 The change in net loss is attributable to a decrease in research organization ("CRO") expenses related to continued progress with the Company's clinical trial of Berubicin, …See details»
Press Releases - CNS Pharmaceuticals
The link you have selected will take you to a site outside CNSPharma.com. CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS …See details»